Newland Pharmaceutical Co., Ltd. (SHE:301277)

Newland Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 19, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	5,838	3,873	4,163	3,850	-	-
Market Cap Growth	54.99%	-6.96%	8.12%	-	-	-
Enterprise Value	5,182	3,072	3,378	3,956	-	-
Last Close Price	14.89	9.64	10.19	9.28	-	-
PE Ratio	41.64	22.31	26.19	29.10	-	-
PS Ratio	8.48	5.33	6.39	6.14	-	-
PB Ratio	3.87	2.51	2.87	2.83	-	-
P/TBV Ratio	4.01	2.57	2.95	2.92	-	-
P/FCF Ratio	-	242.50	25.55	452.81	-	-
P/OCF Ratio	61.77	30.56	16.04	46.47	-	-
EV/Sales Ratio	7.53	4.23	5.19	6.31	-	-
EV/EBITDA Ratio	27.01	14.22	17.72	23.63	-	-
EV/EBIT Ratio	35.55	16.98	20.87	27.22	-	-
EV/FCF Ratio	-148.68	192.33	20.73	465.21	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.31	0.35
Debt / EBITDA Ratio	0.02	0.01	0.01	0.03	0.80	0.69
Debt / FCF Ratio	-	0.19	0.02	0.67	5.34	3.57
Asset Turnover	0.39	0.42	0.41	0.57	0.86	0.90
Inventory Turnover	8.73	11.50	9.30	6.12	4.81	5.81
Quick Ratio	4.86	5.26	7.89	7.14	1.42	1.22
Current Ratio	5.29	5.51	8.29	7.61	1.82	1.51
Return on Equity (ROE)	9.40%	11.56%	11.19%	14.92%	31.91%	46.93%
Return on Assets (ROA)	5.20%	6.61%	6.44%	8.25%	14.32%	18.59%
Return on Capital (ROIC)	6.08%	7.54%	7.18%	9.57%	17.82%	26.01%
Return on Capital Employed (ROCE)	9.30%	11.30%	11.00%	10.50%	30.50%	41.50%
Earnings Yield	2.40%	4.48%	3.82%	3.44%	-	-
FCF Yield	-0.60%	0.41%	3.91%	0.22%	-	-
Dividend Yield	1.92%	2.96%	2.00%	1.83%	-	-
Payout Ratio	79.92%	46.08%	41.94%	5.12%	31.92%	45.98%
Buyback Yield / Dilution	-1.32%	-0.39%	-29.52%	-2.59%	-0.64%	-0.34%
Total Shareholder Return	0.63%	2.57%	-27.51%	-0.75%	-0.64%	-0.34%

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.